JCELL Trademark

Trademark Overview

On Monday, June 21, 2021, a trademark application was filed for JCELL with the United States Patent and Trademark Office. The USPTO has given the JCELL trademark a serial number of 90785763. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 9, 2024. This trademark is owned by jCyte, Inc.. The JCELL trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Cell therapy manufacturing for others; manufacturing of biological cells and cell therapies; Custom manufacturing of biological cells; biological cell manufacturing services via allogeneic progenitor cell platforms
jcell

General Information

Serial Number90785763
Word MarkJCELL
Filing DateMonday, June 21, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements

Goods and ServicesCell therapy manufacturing for others; manufacturing of biological cells and cell therapies; Custom manufacturing of biological cells; biological cell manufacturing services via allogeneic progenitor cell platforms

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, September 6, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamejCyte, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NamejCyte, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events

Event DateEvent Description
Monday, September 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 24, 2021NEW APPLICATION ENTERED
Friday, March 11, 2022ASSIGNED TO EXAMINER
Friday, March 11, 2022NON-FINAL ACTION WRITTEN
Friday, March 11, 2022NON-FINAL ACTION E-MAILED
Friday, March 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 8, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 9, 2022DIVISIONAL REQUEST RECEIVED
Friday, September 9, 2022TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, October 18, 2022ASSIGNED TO LIE
Thursday, December 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 7, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, December 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 1 FILED
Tuesday, October 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 9, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 9, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2024SOU EXTENSION 3 GRANTED
Wednesday, October 9, 2024SOU EXTENSION 3 FILED
Wednesday, April 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2024SOU EXTENSION 2 FILED

Related Keywords

jcell manufacturing cell biological cells allogeneic progenitor platforms services custom therapy